RUA Life Sciences plc

Equities

AOR

GB0033360586

Advanced Medical Equipment & Technology

Market Closed - London S.E. 11:35:23 2024-04-26 am EDT 5-day change 1st Jan Change
10.75 GBX +4.88% Intraday chart for RUA Life Sciences plc -2.27% +9.14%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
RUA Life Sciences expects flat annual revenue on strong second half AN
RUA Life Sciences plc Provides Revenue Guidance for the Year Ended 31 March 2024 CI
Caroline Stretton Resigns as Group Managing Director of RUA Life Sciences plc CI
RUA Life Sciences plc Announces Caroline Stretton Resigns as Director CI
EARNINGS AND TRADING: Half-year loss widens at Triad as revenue falls AN
RUA Life Sciences Strikes Deal for Heart Valve Leaflet Composite Material MT
Rua Life Sciences plc Provides an Update on Recent Developments of the Rua Leaflet Composite CI
Transcript : RUA Life Sciences plc, Q2 2024 Earnings Call, Dec 19, 2023
RUA Life Sciences first half loss widens, expects to turn profitable AN
RUA Life Sciences plc Reports Earnings Results for the Half Year Ended September 30, 2023 CI
RUA Life Sciences shares suspended due to settlement issues AN
Rua Life Sciences Raises Funds via Retail Offer MT
RUA Life Sciences raises GBP4.4 million to accelerate growth AN
Rua Life Sciences Raises GBP4 Million via Share Placing; Stock Plunges MT
AIM WINNERS & LOSERS: Sondrel plummets as Siemens sells entire stake AN
RUA Life Sciences shares fall 43% after GBP4 million equity raise AN
RUA Life Sciences plans USD4.8 million total equity raise AN
Stocks edge lower in quiet Thanksgiving trade AN
AIM WINNERS & LOSERS: RUA Life Science slides after strong week AN
RUA Life Sciences shares fall on worsened performance in first half AN
AIM WINNERS & LOSERS: Intercede raises guidance after interim growth AN
RUA Life Sciences shares soar as testing and new deals progress AN
AIM WINNERS & LOSERS: Oriole inks earn-in deals; Velocys sinks AN
RUA Life Sciences plc Announces Iain Anthony, Director of Clinical and Regulatory Affairs Tenders His Resignation CI
FTSE 100 Closes Higher, Breaking Seven-Day Losing Streak DJ
Chart RUA Life Sciences plc
More charts
RUA Life Sciences plc is a United Kingdom-based holding company of a group of medical device businesses focused on the exploitation of long-term implantable biostable polymer (Elast-Eon). Elast-Eon's biostability is comparable to silicone while exhibiting excellent mechanical, blood contacting and flex-fatigue properties. The Company has four business units: RUA Contract Manufacture, RUA Biomaterials, RUA Vascular and RUA Structural Heart. RUA Contract Manufacture is an end-to-end contract developer and manufacturer of medical devices and implantable fabric specialist. It provides sub-contract manufacturing, assembly, packing and services to the medical device sector from its Class 7 and 8 cleanroom suites. RUA Biomaterials is a licensor of Elast-Eon polymers to the medical device industry. RUA Vascular is engaged in the commercialization of open surgical vascular grafts and patches. RUA Structural Heart is engaged in the development of polymeric leaflet systems for heart valves.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. AOR Stock
  4. News RUA Life Sciences plc
  5. Rua Life Sciences Raises GBP4 Million via Share Placing; Stock Plunges